He didn't want any non shareholders in attendance. It was a purely desperate attempt to stroke the current shareholders. Did anyone ask tough questions like how he's going to deal with the Q3/Q4 SG&A expenses or how he's going to pay to launch Fluticare without another dilutive offering?